UB Paderborn / Katalog / Suche / in CDI

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

The American journal of cardiology, 2001-03, Vol.87 (6), p.805-807

2001

Volltextzugriff (PDF)

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

The American journal of cardiology, 2001-05, Vol.87 (10), p.1160-1163

2001

Volltextzugriff (PDF)

Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

Heart (British Cardiac Society), 2003-12, Vol.89 (12), p.1411-1415

2003

Volltextzugriff (PDF)

Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries

Journal of clinical pathology, 2004-03, Vol.57 (3), p.266-272

2004

Volltextzugriff (PDF)

Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells

European journal of clinical investigation, 2003-10, Vol.33 (10), p.833-839

2003

Volltextzugriff (PDF)

Angiogenesis in myocardial infarction. An acute or chronic process?

European heart journal, 2002-10, Vol.23 (20), p.1604-1608

2002

Volltextzugriff (PDF)

Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers

British journal of biomedical science, 2000, Vol.57 (3), p.207

2000

Volltextzugriff (PDF)

Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer

The International journal of biological markers, 2004-07, Vol.19 (3), p.229-235

2004

Volltextzugriff (PDF)

Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers

British journal of haematology, 2000-08, Vol.110 (2), p.496-497

2000

Volltextzugriff (PDF)

Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia

Atherosclerosis, 2000-08, Vol.151 (2), p.599-599

2000

Volltextzugriff (PDF)

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

Stroke (1970), 2002-09, Vol.33 (9), p.2187-2191

2002

Volltextzugriff (PDF)

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])

The American journal of cardiology, 2003-08, Vol.92 (4), p.400-405

2003

Volltextzugriff (PDF)

Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays

Clinical science (1979), 2001-05, Vol.100 (5), p.567

2001

Volltextzugriff (PDF)

Plasma VEGF and Soluble VEGF Receptor FLT-1 in Proliferative Retinopathy: Relationship to Endothelial Dysfunction and Laser Treatment

Investigative ophthalmology & visual science, 2000-07, Vol.41 (8), p.2115-2119

2000

Volltextzugriff (PDF)

Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management

American journal of hypertension, 2003-01, Vol.16 (1), p.11-20

2003

Volltextzugriff (PDF)

Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers

International journal of cardiology, 2005-04, Vol.100 (2), p.207-212

2005

Volltextzugriff (PDF)

Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFlt-1) in human breast cancer

The International journal of biological markers, 2004, Vol.19 (3), p.229-235

2004

Volltextzugriff (PDF)

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt‐1, in haematological cancers: A comparison with breast cancer

American journal of hematology, 2001-01, Vol.66 (1), p.59-61

2001

Volltextzugriff (PDF)

Angiogenesis, thromboenesis, endothelial dysfunction and angiographic severity of coronary artery disease

Heart (British Cardiac Society), 2003, Vol.89 (12), p.1411-1415

2003

Volltextzugriff (PDF)

O14 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor (sFlt-1) levels in coronary artery disease and peripheral artery disease

Blood coagulation & fibrinolysis, 1999-12, Vol.10 (8), p.536

1999

Volltextzugriff (PDF)

Angiogenesis and endothelial damage in acute myocardial infarction: an acute or chronic process?

Atherosclerosis. Supplements, 2001-05, Vol.2 (2), p.145-145

2001

Volltextzugriff (PDF)

Vascular endothelial growth factor, soluble receptor Flt-1 and von willebrand factor in coronary artery disease: relationship to disease severity

Atherosclerosis. Supplements, 2001-05, Vol.2 (2), p.145-145

2001

Volltextzugriff (PDF)

Is endothelial function and vascular endothelial growth factor, an index of angiogenesis, affected by intensified blood pressure treatment in high-risk hypertensives?

Atherosclerosis. Supplements, 2001-05, Vol.2 (2), p.144-144

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries

Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells

Angiogenesis in myocardial infarction. An acute or chronic process?

Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers

Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancer

Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers

Successful therapy reduces levels of vascular endothelial growth factor (VEGF) in patients with hypertension and patients with hypercholesterolemia

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])

Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays

Plasma VEGF and Soluble VEGF Receptor FLT-1 in Proliferative Retinopathy: Relationship to Endothelial Dysfunction and Laser Treatment

Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management

Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers

Circulating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFlt-1) in human breast cancer

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt‐1, in haematological cancers: A comparison with breast cancer

Angiogenesis, thromboenesis, endothelial dysfunction and angiographic severity of coronary artery disease

O14 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor (sFlt-1) levels in coronary artery disease and peripheral artery disease

Angiogenesis and endothelial damage in acute myocardial infarction: an acute or chronic process?

Vascular endothelial growth factor, soluble receptor Flt-1 and von willebrand factor in coronary artery disease: relationship to disease severity

Is endothelial function and vascular endothelial growth factor, an index of angiogenesis, affected by intensified blood pressure treatment in high-risk hypertensives?

Suchergebnisse filtern